| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Matinas BioPharma Holdings, Inc. | Director | Stock option (right to buy) | 437,244 | 01 Nov 2023 | Direct | ||
| Marker Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 147,611 | 31 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | 31 Oct 2025 | 1 | $0 | 4 | Director | 04 Nov 2025, 17:09 |
| MRKR | Marker Therapeutics, Inc. | 31 Oct 2025 | 0 | $0 | 3 | Director | 04 Nov 2025, 16:54 |
| MTNB | Matinas BioPharma Holdings, Inc. | 01 Nov 2023 | 1 | $0 | 4 | Director | 03 Nov 2023, 16:49 |
| MTNB | Matinas BioPharma Holdings, Inc. | 14 Nov 2022 | 1 | $0 | 4 | Director | 16 Nov 2022, 20:36 |
| MTNB | Matinas BioPharma Holdings, Inc. | 01 Nov 2021 | 1 | $0 | 4 | Director | 02 Nov 2021, 16:13 |
| MTNB | Matinas BioPharma Holdings, Inc. | 01 Nov 2021 | 0 | $0 | 3 | Director | 02 Nov 2021, 16:05 |